Embassy of Lithuania in Singapore’s Post

👉 𝐐𝐮𝐢𝐜𝐤 𝐁𝐲𝐭𝐞𝐬: New Wave Biotech, a London-based AI-driven bioprocess simulation startup, has secured €1.2 million in funding from EIT Food and Innovate UK. Founded in 2022 by Zoe Yu Tung Law and Oli Hall, the company aims to revolutionize biomanufacturing by enhancing the design, commercialization, and scalability of sustainable production processes. Their Bioprocess Foresight platform utilizes AI to simulate bioprocesses, predicting outputs, costs, and sustainability impacts, thereby accelerating the transition from lab to market. This investment will support New Wave Biotech in expanding its team, advancing technology, and broadening its customer base. #Biotech #AI #SustainableManufacturing #Innovation #Funding #Bioprocessing #SyntheticBiology #AlternativeProteins #TechNews #StartupGrowth

What could $73M in funding mean for the future of protein design and biotech innovation? Exciting times are ahead in the biotech sector as Cradle, a pioneering company focused on AI-driven protein design, has successfully raised an impressive $73 million to enhance its labs and expand its talented team. This substantial investment comes on the heels of growing recognition that leveraging AI technology is not just beneficial but essential for accelerating research and development processes in biotechnology. As more companies navigate complex biological challenges, Cradle’s advanced platform could be a game-changer. The infusion of funds will allow them to streamline their operations and innovate at unprecedented speeds. This raises intriguing questions about how rapidly evolving technologies will reshape our understanding of proteins — the building blocks of life! With corporate investments pouring into startups like Cradle who are committed to integrating AI with lab-based science then what does this mean for your industry? Will we soon see breakthroughs that can help address global health issues or improve sustainable practices? Join us in exploring the intersection of artificial intelligence and biotechnology! Share your thoughts below ⬇️ 💡 Connect with startups to drive your corporate innovation 🚀 Book a meeting! https://lnkd.in/dFYwmbHq #Biotech #AI #ProteinDesign #Innovation #Funding #Startups #TechNews #CradleAI #LifeSciences #CorporateInnovation Read more here: https://lnkd.in/dRFpxjmh

🔬 Top companies Revolutionizing Lab Automation in Biotechnology 🚀 As the demand for efficiency and precision in biotechnology grows, innovative lab automation companies are leading the way. Companies like Opentrons Labworks Inc. are democratizing lab automation with affordable robotic pipettes, while Strateos is pioneering cloud-based lab automation, allowing labs to run experiments remotely. LabGenius leverages AI-driven platforms for protein engineering, pushing the boundaries of biotech research. Emerging startups are making lab automation more accessible, while industry veterans are driving scalability and intelligence. Together, they're transforming biotech with innovative solutions. #LabAutomation #Biotechnology #AI #LifeSciences #Startups #Innovation #AutomationTech #Biotech

What could $73M in funding mean for the future of protein design and biotech innovation? Exciting times are ahead in the biotech sector as Cradle, a pioneering company focused on AI-driven protein design, has successfully raised an impressive $73 million to enhance its labs and expand its talented team. This substantial investment comes on the heels of growing recognition that leveraging AI technology is not just beneficial but essential for accelerating research and development processes in biotechnology. As more companies navigate complex biological challenges, Cradle’s advanced platform could be a game-changer. The infusion of funds will allow them to streamline their operations and innovate at unprecedented speeds. This raises intriguing questions about how rapidly evolving technologies will reshape our understanding of proteins — the building blocks of life! With corporate investments pouring into startups like Cradle who are committed to integrating AI with lab-based science then what does this mean for your industry? Will we soon see breakthroughs that can help address global health issues or improve sustainable practices? Join us in exploring the intersection of artificial intelligence and biotechnology! Share your thoughts below ⬇️ 💡 Connect with startups to drive your corporate innovation 🚀 Book a meeting! https://lnkd.in/dFYwmbHq #Biotech #AI #ProteinDesign #Innovation #Funding #Startups #TechNews #CradleAI #LifeSciences #CorporateInnovation Read more here: https://lnkd.in/dRFpxjmh

What could $73M in funding mean for the future of protein design and biotech innovation? Exciting times are ahead in the biotech sector as Cradle, a pioneering company focused on AI-driven protein design, has successfully raised an impressive $73 million to enhance its labs and expand its talented team. This substantial investment comes on the heels of growing recognition that leveraging AI technology is not just beneficial but essential for accelerating research and development processes in biotechnology. As more companies navigate complex biological challenges, Cradle’s advanced platform could be a game-changer. The infusion of funds will allow them to streamline their operations and innovate at unprecedented speeds. This raises intriguing questions about how rapidly evolving technologies will reshape our understanding of proteins — the building blocks of life! With corporate investments pouring into startups like Cradle who are committed to integrating AI with lab-based science then what does this mean for your industry? Will we soon see breakthroughs that can help address global health issues or improve sustainable practices? Join us in exploring the intersection of artificial intelligence and biotechnology! Share your thoughts below ⬇️ 💡 Connect with startups to drive your corporate innovation 🚀 Book a meeting! https://lnkd.in/dFYwmbHq #Biotech #AI #ProteinDesign #Innovation #Funding #Startups #TechNews #CradleAI #LifeSciences #CorporateInnovation Read more here: https://lnkd.in/dRFpxjmh

What could $73M in funding mean for the future of protein design and biotech innovation? Exciting times are ahead in the biotech sector as Cradle, a pioneering company focused on AI-driven protein design, has successfully raised an impressive $73 million to enhance its labs and expand its talented team. This substantial investment comes on the heels of growing recognition that leveraging AI technology is not just beneficial but essential for accelerating research and development processes in biotechnology. As more companies navigate complex biological challenges, Cradle’s advanced platform could be a game-changer. The infusion of funds will allow them to streamline their operations and innovate at unprecedented speeds. This raises intriguing questions about how rapidly evolving technologies will reshape our understanding of proteins — the building blocks of life! With corporate investments pouring into startups like Cradle who are committed to integrating AI with lab-based science then what does this mean for your industry? Will we soon see breakthroughs that can help address global health issues or improve sustainable practices? Join us in exploring the intersection of artificial intelligence and biotechnology! Share your thoughts below ⬇️ 💡 Connect with startups to drive your corporate innovation 🚀 Book a meeting! https://lnkd.in/dFYwmbHq #Biotech #AI #ProteinDesign #Innovation #Funding #Startups #TechNews #CradleAI #LifeSciences #CorporateInnovation Read more here: https://lnkd.in/dRFpxjmh

What could $73M in funding mean for the future of protein design and biotech innovation? Exciting times are ahead in the biotech sector as Cradle, a pioneering company focused on AI-driven protein design, has successfully raised an impressive $73 million to enhance its labs and expand its talented team. This substantial investment comes on the heels of growing recognition that leveraging AI technology is not just beneficial but essential for accelerating research and development processes in biotechnology. As more companies navigate complex biological challenges, Cradle’s advanced platform could be a game-changer. The infusion of funds will allow them to streamline their operations and innovate at unprecedented speeds. This raises intriguing questions about how rapidly evolving technologies will reshape our understanding of proteins — the building blocks of life! With corporate investments pouring into startups like Cradle who are committed to integrating AI with lab-based science then what does this mean for your industry? Will we soon see breakthroughs that can help address global health issues or improve sustainable practices? Join us in exploring the intersection of artificial intelligence and biotechnology! Share your thoughts below ⬇️ 💡 Connect with startups to drive your corporate innovation 🚀 Book a meeting! https://lnkd.in/dTxGsKrN #Biotech #AI #ProteinDesign #Innovation #Funding #Startups #TechNews #CradleAI #LifeSciences #CorporateInnovation Read more here: https://lnkd.in/dqUEeaBb

Look at this awesome article about Thya and the story behind it!

🎉 Introducing The Biotech Startup Standard! 🎉 Welcome to the inaugural issue of The Biotech Startup Standard, your premier source for insights and guidance in the development of new medicinal products. This magazine was born during a brainstorming session between us at ADRES and a few industry colleagues over coffee. We realized there was a gap in accessible, practical information for biotech startups navigating the complex journey from concept to market. In this first issue, we delve into the critical topic of technology transfer. Articles are written by professionals who know this field inside out. Here are some highlights: 1. Cutting-Edge Insights: Dive into the latest trends and breakthroughs in biotech. Our articles provide actionable insights to help startups thrive. 2. Expert Authors: Our contributors are seasoned professionals who understand the intricacies of tech transfer. Expect well-researched, practical advice. 3. Industry Impact: The magazine bridges the gap between research and commercialization. Share it with your network to empower fellow biotech enthusiasts! 🌟 🔗 Read the full magazine here: The Biotech Startup Standard https://lnkd.in/dRaUVyqF Feel free to share this exciting resource with your network! 🚀💡 #Biotech #Startup #TechTransfer #MedicinalProducts A big 𝐓𝐇𝐀𝐍𝐊𝐒 to these incredible authors and people! Rivka Zaibel Roy Zaibel Dorit Cohen Carmon Tali Aloya, Ph.D. Michal Roll Darron Segall, MHS Michal Zilberberg Elad Mark Tamar Oved Hadar Solomon Hili Rashkovan

Aropha Secures $1M for Biodegradable AI Innovations - Seed Funding Achievement: Aropha, based in Bedford, OH, secures $1M in seed funding led by Comeback Capital, with Lightbank and Right Side Capital Management participating. - Expansion and Development Plans: The funding will be used to expand laboratory operations, enhance industry awareness, and develop the biodegradation prediction model, ArophaAI. - Growth and Impact: Aropha has assisted over 80 customers with biodegradation testing, showing significant revenue growth of 190% year-over-year, and has released ArophaAI-2 for free. Subscribe to our daily newsletter here for more AI news https://lnkd.in/du9VtxiF #Startups #VentureCapital #Sustainability #Innovation #Technology #Entrepreneurship #Biotechnology #Research #Funding #ScienceAndTechnology #AI